United Breweries Limited (UBL.NS)
Bengaluru, KA, IN
United Breweries Limited engages in manufacture, purchase, and sale of beer and non-alcoholic beverages in India and internationally. The company offers beer products under the Heineken Original, Heineken Silver, Kingfisher Premium, Kingfisher Strong, Kingfisher Ultra, Kingfisher Ultra Max, Kingfisher Ultra Witbier, Amstel Bier, Amstel Grande, Bullet, Bullet Super Strong, Cannon 10000, Zingaro, Kingfisher Storm, Kingfisher Blue, Kingfisher Flavour Mango and lemon, Kalyani Black Label, UB Export Lager, UB Export Strong, London Pilsner Premium, London Pilsner Premium Strong, and Queenfisher brands; and non-alcoholic products under the Kingfisher Premium Packaged Drinking Water, Kingfisher Strong Power Soda, Kingfisher Ultra-Premium Soda, and Heineken 0.0. It also licenses its brands; and offers contract manufacturing services. In addition, the company is involved in scrap sales. The company was founded in 1915 and is based in Bengaluru, India. United Breweries Limited operates as a subsidiary of Heineken N.V.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.65% | -1.58% | -3.52% | -13.46% | -21.83% | -13.49% | -33.81% | -0.64% | +16.24% | +76.22% | +808.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | -1 |
| Buy | 6 | 0 |
| Hold | 3 | 0 |
| Sell | 3 | 0 |
| Strong Sell | 4 | 0 |
-
Revenue growth+9.8% Q1'26: +12.4% (vs Q1'25)
-
EPS growth+7.7% Q1'26: +4.3% (vs Q1'25)
-
FCF margin+0.2% Q1'26: +1.0% (vs Q1'25)
-
EBIT margin+6.9% Q1'26: +2.0% (vs Q1'25)
-
ROIC+9.8% Q1'26: +3.0% (vs Q1'25)
-
Share dilution0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA0.73× Q1'26: 2.72× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 9 Rev. Ana. 10 EPS Ana. |
Mar 2027 9 Rev. Ana. 6 EPS Ana. |
Mar 2028 10 Rev. Ana. 10 EPS Ana. |
Mar 2029 5 Rev. Ana. 4 EPS Ana. |
Mar 2030 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
30.60B
est: 31.71B (-3.5%)
|
33.81B
est: 37.87B (-10.7%)
|
35.79B
est: 42.06B (-14.9%)
|
37.88B
est: 43.84B (-13.6%)
|
41.75B
est: 48.17B (-13.3%)
|
45.88B
est: 50.74B (-9.6%)
|
45.12B
est: 50.07B (-9.9%)
|
53.63B
est: 54.95B (-2.4%)
|
62.15B
est: 64.95B (-4.3%)
|
62.60B
est: 66.92B (-6.5%)
|
40.59B
est: 43.74B (-7.2%)
|
56.05B
est: 58.20B (-3.7%)
|
73.31B
est: 75.44B (-2.8%)
|
78.76B
est: 79.94B (-1.5%)
|
85.93B
est: 89.39B (-3.9%)
|
94.75B
93.77B – 97.95B
+6.0% YoY
|
104.95B
101.65B – 108.72B
+10.8% YoY
|
116.26B
112.49B – 120.62B
+10.8% YoY
|
125.80B
121.78B – 130.43B
+8.2% YoY
|
137.68B
133.28B – 142.75B
+9.4% YoY
|
| EBITDA |
4.35B
est: 2.93B (+48.5%)
|
4.61B
est: 3.72B (+23.8%)
|
5.13B
est: 3.37B (+52.4%)
|
6.11B
est: 3.87B (+58.0%)
|
6.58B
est: 5.10B (+29.0%)
|
7.74B
est: 5.48B (+41.2%)
|
6.93B
est: 5.78B (+20.0%)
|
9.15B
est: 6.29B (+45.5%)
|
11.70B
est: 9.78B (+19.7%)
|
8.84B
est: 11.56B (-23.5%)
|
4.24B
est: 5.93B (-28.6%)
|
7.26B
est: 8.47B (-14.3%)
|
6.32B
est: 10.01B (-36.8%)
|
7.70B
est: 12.97B (-40.7%)
|
8.50B
est: 8.92B (-4.7%)
|
9.47B
9.37B – 9.79B
+6.2% YoY
|
10.49B
10.16B – 10.86B
+10.8% YoY
|
11.62B
11.24B – 12.05B
+10.8% YoY
|
12.57B
12.17B – 13.03B
+8.2% YoY
|
13.76B
13.32B – 14.27B
+9.4% YoY
|
| EBIT |
3.05B
est: 1.76B (+73.1%)
|
3.12B
est: 2.65B (+17.8%)
|
3.43B
est: 2.69B (+27.7%)
|
4.13B
est: 3.20B (+29.0%)
|
4.51B
est: 4.36B (+3.3%)
|
5.30B
est: 4.35B (+21.8%)
|
4.06B
est: 4.87B (-16.6%)
|
6.55B
est: 3.97B (+64.8%)
|
9.10B
est: 7.71B (+18.0%)
|
5.99B
est: 9.32B (-35.7%)
|
1.92B
est: 4.30B (-55.3%)
|
5.09B
est: 6.13B (-17.0%)
|
4.22B
est: 7.25B (-41.8%)
|
5.58B
est: 9.39B (-40.6%)
|
6.17B
est: 6.22B (-0.8%)
|
6.61B
6.54B – 6.83B
+6.2% YoY
|
7.32B
7.09B – 7.58B
+10.8% YoY
|
8.11B
7.85B – 8.41B
+10.8% YoY
|
8.77B
8.49B – 9.10B
+8.2% YoY
|
9.60B
9.30B – 9.96B
+9.4% YoY
|
| Net Income |
1.47B
est: 1.21B (+22.2%)
|
1.27B
est: 1.76B (-28.0%)
|
1.72B
est: 1.40B (+23.3%)
|
2.26B
est: 1.79B (+26.0%)
|
2.60B
est: 2.53B (+2.8%)
|
2.98B
est: 2.73B (+9.4%)
|
2.30B
est: 2.96B (-22.4%)
|
3.94B
est: 2.49B (+58.3%)
|
5.63B
est: 4.69B (+19.9%)
|
4.28B
est: 5.84B (-26.8%)
|
1.13B
est: 3.08B (-63.2%)
|
3.65B
est: 4.39B (-16.8%)
|
3.04B
est: 5.20B (-41.5%)
|
4.10B
est: 6.73B (-39.1%)
|
4.42B
est: 5.48B (-19.4%)
|
4.75B
4.28B – 6.14B
-13.2% YoY
|
5.94B
3.81B – 7.45B
+24.9% YoY
|
8.47B
6.63B – 9.76B
+42.7% YoY
|
9.03B
8.65B – 9.46B
+6.6% YoY
|
12.71B
12.19B – 13.32B
+40.8% YoY
|
| SGA |
—
est: 3.14B (-100.0%)
|
9.39B
est: 42.99M (+21,744.9%)
|
13.54B
est: 14.23B (-4.8%)
|
11.82B
est: 15.40B (-23.3%)
|
11.01B
est: 17.38B (-36.7%)
|
7.85B
est: 18.97B (-58.6%)
|
7.54B
est: 14.80B (-49.1%)
|
7.51B
est: 16.10B (-53.4%)
|
8.44B
est: 19.17B (-56.0%)
|
9.11B
est: 19.20B (-52.5%)
|
7.35B
est: 14.20B (-48.2%)
|
8.21B
est: 20.26B (-59.5%)
|
9.28B
est: 23.96B (-61.3%)
|
10.16B
est: 31.04B (-67.3%)
|
11.36B
est: 14.37B (-20.9%)
|
15.26B
15.10B – 15.77B
+6.2% YoY
|
16.90B
16.37B – 17.51B
+10.8% YoY
|
18.72B
18.11B – 19.43B
+10.8% YoY
|
20.26B
19.61B – 21.00B
+8.2% YoY
|
22.17B
21.46B – 22.99B
+9.4% YoY
|
| EPS |
5.46
est: 7.31 (-25.3%)
|
4.69
est: 6.77 (-30.7%)
|
6.51
est: 8.42 (-22.7%)
|
8.55
est: 8.26 (+3.5%)
|
9.83
est: 11.14 (-11.8%)
|
11.30
est: 12.48 (-9.5%)
|
8.68
est: 12.46 (-30.3%)
|
14.91
est: 17.60 (-15.3%)
|
21.29
est: 23.11 (-7.9%)
|
16.18
est: 18.20 (-11.1%)
|
4.28
est: 5.19 (-17.5%)
|
13.82
est: 12.90 (+7.2%)
|
11.50
est: 16.87 (-31.8%)
|
15.51
est: 16.80 (-7.7%)
|
16.71
est: 19.58 (-14.7%)
|
17.99
16.18 – 23.22
-8.2% YoY
|
22.46
14.40 – 28.17
+24.9% YoY
|
32.04
25.07 – 36.93
+42.7% YoY
|
34.16
32.74 – 35.79
+6.6% YoY
|
48.10
46.10 – 50.40
+40.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-10 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vivek Gupta | MD, Chief Executive Officer & Director | 107M | male |
| Jorn Elimar Kersten | Chief Financial Officer & WholeTime Director | 46M | male |
| Kavita Singh | Chief Human Resource Officer | — | female |
| Neha Munjral | Director of Legal | — | female |
| Nikhil Malpani | Company Secretary & Compliance Officer | — | male |
| Rakesh Kumar | Chief Sales Officer & Director of Sales | — | male |
| Suresh Mandalika | Chief Digital & Technology Officer | — | male |
| Vikram Bahl | Chief Marketing Officer | — | male |
| Garima Singh | Chief Corporate Affairs Officer | — | female |
| Xavier Jadin | Chief Supply Chain officer | — | male |
| Harsh Sharma | Chief Transformation & Strategy Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for UBL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
